RYANN GELON GESTOPA: Open Payments
NPI 1841933538 · NORTHRIDGE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,480 in 51 payments from 18 companies in 2025. Trend: 2023 $361 · 2024 $813 · 2025 $1,480
Food & beverage: $1,380Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $372 |
| Janssen Biotech, Inc. | 4 | $272 |
| Sumitomo Pharma America, Inc. | 8 | $201 |
| Neurelis, Inc. | 2 | $89 |
| Antares Pharma, Inc. | 3 | $63 |
| SK Life Science, Inc. | 2 | $57 |
| IMMUNITYBIO, INC. | 2 | $56 |
| Dendreon Pharmaceuticals LLC | 2 | $51 |
| Teleflex LLC | 2 | $50 |
| UROGEN PHARMA, INC. | 1 | $36 |
Products named: GEMTESA, ERLEADA, UBRELVY, QULIPTA, RYBREVANT, VALTOCO, XYOSTED, ANKTIVA.
Industry payments across CA — which companies pay providers there.
